查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1625479

自體免疫疾病診斷市場規模、佔有率、趨勢、行業分析報告（按產品類型、檢測類型、最終用戶和地區）- 市場預測，2025-2034 年

Autoimmune Disease Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Product, Type, Test Type, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 120 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，到2034年全球自體免疫疾病診斷市場規模預計將達到71.4632億美元。該研究報告對當前市場動態提供了詳細的見解，並對未來市場成長進行了分析。

自體免疫疾病診斷市場是醫療保健和診斷產業的一個分支。市場專注於透過先進的診斷工具和技術來識別和管理自體免疫疾病。當免疫系統攻擊身體自體組織時，就會發生自體免疫疾病，導致各種慢性、亞臨床症狀。這個市場涵蓋用於檢測這些情況的診斷測試和技術，包括血液檢查、影像技術和分子檢測。

全球自體免疫疾病的盛行率不斷上升，推動了對早期和準確診斷工具的需求。隨著對這些疾病的認識不斷提高，患者和醫療保健提供者越來越要求更準確、更有效的診斷解決方案。此外，個人化醫療和先進治療方法的日益普及需要準確的診斷，從而進一步推動市場成長。政府對自體免疫疾病和診斷研究的措施和資金正在促進新診斷方法的開發，從而增加市場機會。

2021年，加速藥物夥伴關係（AMP）計畫推出了AMP AIM（加速藥物夥伴關係自體免疫和免疫介導疾病）計畫。 AMP 自體免疫和免疫介導疾病 (AMP AIM) 計劃透過提高人們對自體免疫疾病的認識和鼓勵早期篩檢來推動市場發展。

自體免疫疾病診斷市場正在快速轉向先進的自動化診斷解決方案，以提供更高的準確性和更快的結果。人工智慧（AI）和機器學習（ML）融入診斷平台正在改變自體免疫疾病的檢測和監測方式，提高效率和準確性。此外，人們越來越關注開發比傳統方法更適合患者的非侵入性診斷技術。

2022年7月，KSL Beutner Laboratories（Beutner）宣佈在美國推出其間接免疫螢光（IIF）血清血液檢測。此檢測可有效檢測層黏連蛋白 332，一種與持續性自體免疫疾病黏膜類天皰瘡 (MMP) 相關的抗原。診斷方法的這些發展正在推動自體免疫疾病診斷市場的成長。

自體免疫疾病診斷市場報告重點

按類型劃分，系統性自體免疫疾病診斷部門佔據了自體免疫疾病診斷市場收入佔有率的主導地位，這主要是由於醫療保健提供者和患者的認識不斷提高。

根據測試類型，由於自體免疫疾病的盛行率不斷增加和診斷技術的進步，抗核抗體 (ANA) 測試部分預計在預測期內將實現最高複合年增長率。

北美憑藉先進的醫療保健基礎設施和大量的醫療研發資金佔據市場主導地位。

由於中國和印度等國家醫療保健產業的成長以及自體免疫疾病的盛行率不斷上升，預計亞太地區將在預測期內實現最高的複合年增長率。

全球市場的主要參與者有Abbott、AESKU.DIAGNOSTICS、Beckman Coulter、BIOMERIEUX、Bio-Rad Laboratories、EUROIMMUN、F. Hoffmann-La Roche Ltd、Inova Diagnostics（Werfen Group）、Myriad Genetics、Quest Diagnostics、Scipher Medicine、Siemens Healthcare Private Limited、Thermo Fisher Scientific Inc.。

目錄

第 1 章簡介

第 2 章執行摘要

第 3 章 研究方法

第 4 章。
  • 類型快照 自體免疫疾病診斷市場動態
    • 推動因素和機遇
      • 加強意識和篩檢計劃
      • 增加對醫療保健支出和研究的投資
  • 阻礙因素和課題
      • 需要很長時間才能得到結果，並且需要進行多次診斷測試
  • PESTEL 分析
  • 自體免疫疾病診斷市場類型趨勢
  • 價值鏈分析
  • COVID-19 影響分析

5. 全球自體免疫疾病診斷市場（按產品劃分）

  • 主要發現
  • 簡介
  • 耗材和檢測試劑盒
  • 設備

6. 全球自體免疫疾病診斷市場（按類型）

  • 主要發現
  • 簡介
  • 系統性自體免疫疾病的診斷
  • 局部自體免疫疾病的診斷

7. 全球自體免疫疾病診斷市場（按測試類型）

  • 主要發現
  • 簡介
  • 抗核抗體（ANA）檢測
  • 自體抗體檢測 全血球計數 (CBC)
  • 綜合代謝面板
  • C反應蛋白（CRP）
  • 其他

8. 全球自體免疫疾病診斷市場（依最終用戶劃分）

  • 主要發現
  • 簡介
  • 醫院
  • 診斷中心
  • 實驗室

9. 全球自體免疫疾病診斷市場（按地區）

  • 主要發現
  • 簡介
      2020 年至 2034 年自體免疫疾病診斷市場區域評估
  • 北美洲
    • 2020 年至 2034 年，北美各產品類別
    • 2020 年至 2034 年，北美按類型劃分 北美，依測試類型，2020 年至 2034 年
    • 北美，依最終使用者劃分，2020 年至 2034 年
    • 美國
    • 加拿大
  • 歐洲
      歐洲，依產品分類，2020-2034 年 歐洲，依類型，2020 年至 2034 年 2020 年至 2034 年歐洲依測試類型劃分 2020 年至 2034 年歐洲終端用戶狀況
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲國家
    亞太地區
      亞太地區：依產品分類，2020 年至 2034 年 2020 年至 2034 年亞太地區各類產品 亞太地區，依測試類型，2020 年至 2034 年 亞太地區：依最終使用者分類，2020 年至 2034 年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲
      中東和非洲：依產品分類，2020 年至 2034 年 2020 年至 2034 年中東和非洲各類型 中東和非洲：按測試類型，2020 年至 2034 年
    • 中東和非洲：按最終用戶劃分，2020 年至 2034 年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東和非洲地區
  • 拉丁美洲
    • 拉丁美洲，依產品劃分，2020 年至 2034 年
    • 2020 年至 2034 年拉丁美洲各類型
    • 拉丁美洲，依測試類型，2020 年至 2034 年
    • 2020 年至 2034 年拉丁美洲最終用戶分佈
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他拉丁美洲國家

第 10 章 競爭格局

  • 擴張與收購分析
    • 放大
    • 收購
  • 夥伴關係/協作/協定/揭露

第 11 章 公司簡介

  • Abbott
  • AESKU.DIAGNOSTICS
  • Beckman Coulter, Inc.
  • BIOMERIEUX
  • Bio-Rad Laboratories, Inc.
  • EUROIMMUN
  • F. Hoffmann-La Roche Ltd
  • Inova Diagnostics（Werfen Group）
  • Myriad Genetics, Inc.
  • Quest Diagnostics
  • Scipher Medicine
  • Siemens Healthcare Private Limited
  • Thermo Fisher Scientific Inc.
Product Code: PM1299

The global autoimmune disease diagnostics market size is expected to reach USD 7,146.32 million by 2034, according to a new study by Polaris Market Research. The report "Autoimmune Disease Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Product, Type, Test Type, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034." gives a detailed insight into current market dynamics and provides analysis on future market growth.

The autoimmune disease diagnostics market is a sector within the healthcare and diagnostic industry. The market focuses on the identification and management of autoimmune diseases through advanced diagnostic tools and techniques. Autoimmune diseases occur when the immune system attacks the body's tissues, leading to a range of chronic and potential conditions. The market encompasses diagnostic tests and technologies used to detect these conditions, including blood tests, imaging techniques, and molecular assays.

The increasing prevalence of autoimmune diseases globally drives demand for early and accurate diagnostic tools. As awareness of these conditions grows, patients and healthcare providers seek more precise and efficient diagnostic solutions. Additionally, the rising adoption of personalized medicine and advanced treatment approaches necessitates accurate diagnostics, further boosting market growth. Government initiatives and funding for research into autoimmune diseases and diagnostics are contributing to the development of new diagnostic methods, thereby enhancing market opportunities.

In 2021, the Accelerating Medicines Partnership (AMP) program introduced the Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases (AMP AIM) program. The AMP Autoimmune and Immune-Mediated Diseases (AMP AIM) initiative is driving the market by increasing awareness and promoting early screening for autoimmune diseases.

The autoimmune disease diagnostics market is experiencing swift to advanced and automated diagnostic solutions that provide higher accuracy and faster results. Integration of artificial intelligence (AI) and machine learning (ML) into diagnostic platforms is transforming how autoimmune diseases are detected and monitored, improving efficiency and precision. Furthermore, there is an increasing focus on developing noninvasive diagnostic techniques, which provide a more patient-friendly alternative to traditional methods.

In July 2022, KSL Beutner Laboratories (Beutner) announced the launch of an indirect immunofluorescence (IIF) serum blood test in the US. The test effectively detects laminin 332, an antigen linked to the persistent autoimmune condition mucous membrane pemphigoid (MMP). These increasing developments in diagnostic methods drive the autoimmune disease diagnostics market growth.

Autoimmune Disease Diagnostics Market Report Highlights

Based on type, the systemic autoimmune disease diagnostics segment dominated the autoimmune disease diagnostics market revenue share, mainly attributed to increased awareness among healthcare providers and patients.

The antinuclear antibody (ANA) tests segment, by test type, is expected to register the highest CAGR during the forecast period, owing to the increasing prevalence of autoimmune diseases and advancements in diagnostic technologies.

North America dominated the market due to advanced healthcare infrastructure and substantial funding for medical research and development.

Asia Pacific is expected to register the highest CAGR during the forecast period, owing to growing healthcare sectors in countries such as China and India and the increasing prevalence of autoimmune diseases.

A few global key market players are Abbott; AESKU.DIAGNOSTICS; Beckman Coulter, Inc.; BIOMERIEUX; Bio-Rad Laboratories, Inc.; EUROIMMUN; F. Hoffmann-La Roche Ltd; Inova Diagnostics (Werfen Group); Myriad Genetics, Inc.; Quest Diagnostics; Scipher Medicine; Siemens Healthcare Private Limited; and Thermo Fisher Scientific Inc.

Polaris Market Research has segmented the autoimmune disease diagnostics market report on the basis of product, type, test type, end user, and region:

By Product Outlook (Revenue - USD Million, 2020-2034)

  • Consumables and Assay Kits
  • Instruments

By Type Outlook (Revenue - USD Million, 2020-2034)

  • Systemic Autoimmune Disease Diagnostics
  • Rheumatoid Arthritis
  • Ankylosing Spondylitis
  • Systemic Lupus Erythematosus (SLE)
  • Others
  • Localized Autoimmune Disease Diagnostics
  • Multiple Sclerosis
  • Type 1 Diabetes
  • Hashimoto's Thyroiditis
  • Idiopathic Thrombocytopenic Purpura
  • Others

By Test Type Outlook (Revenue - USD Million, 2020-2034)

  • Antinuclear Antibody (ANA) Tests
  • Autoantibody Tests
  • Complete Blood Count (CBC)
  • Comprehensive Metabolic Panel
  • C-Reactive Protein (CRP)
  • Others

By End User Outlook (Revenue - USD Million, 2020-2034)

  • Hospitals
  • Diagnostics Centers
  • Research Laboratories

By Regional Outlook (Revenue - USD Million, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Malaysia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Autoimmune Disease Diagnostics Market Insights

  • 4.1. Autoimmune Disease Diagnostics Market - Type Snapshot
  • 4.2. Autoimmune Disease Diagnostics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increased Awareness and Screening Programs
      • 4.2.1.2. Rising Healthcare Expenditure and Investments in Research
  • 4.3. Restraints and Challenges
      • 4.3.1.1. Prolonged Turnaround Time for Results and Requirement for Multiple Diagnostic Tests
  • 4.4. Porter's Five Forces Analysis
    • 4.4.1. Bargaining Power of Suppliers (Moderate)
    • 4.4.2. Threats of New Entrants (Low)
    • 4.4.3. Bargaining Power of Buyers (Moderate)
    • 4.4.4. Threat of Substitute (Moderate)
    • 4.4.5. Rivalry Among Existing Firms (High)
  • 4.5. PESTEL Analysis
  • 4.6. Autoimmune Disease Diagnostics Market Type Trends
  • 4.7. Value Chain Analysis
  • 4.8. COVID-19 Impact Analysis

5. Global Autoimmune Disease Diagnostics Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • 5.3. Consumables and Assay Kits
    • 5.3.1. Global Autoimmune Disease Diagnostics Market, by Consumables and Assay Kits, by Region, 2020-2034 (USD million)
  • 5.4. Instruments
    • 5.4.1. Global Autoimmune Disease Diagnostics Market, by Instruments, by Region, 2020-2034 (USD million)

6. Global Autoimmune Disease Diagnostics Market, by Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • 6.3. Systemic Autoimmune Disease Diagnostics
    • 6.3.1. Global Autoimmune Disease Diagnostics Market, by Systemic Autoimmune Disease Diagnostics, by Region, 2020-2034 (USD million)
    • 6.3.2. Rheumatoid Arthritis
      • 6.3.2.1. Global Autoimmune Disease Diagnostics Market, by Rheumatoid Arthritis, by Region, 2020-2034 (USD million)
    • 6.3.3. Ankylosing Spondylitis
      • 6.3.3.1. Global Autoimmune Disease Diagnostics Market, by Ankylosing Spondylitis, by Region, 2020-2034 (USD million)
    • 6.3.4. Systemic Lupus Erythematosus (SLE)
      • 6.3.4.1. Global Autoimmune Disease Diagnostics Market, by Systemic Lupus Erythematosus (SLE), by Region, 2020-2034 (USD million)
    • 6.3.5. Others
      • 6.3.5.1. Global Autoimmune Disease Diagnostics Market, by Others, by Region, 2020-2034 (USD million)
  • 6.4. Localized Autoimmune Disease Diagnostics
    • 6.4.1. Global Autoimmune Disease Diagnostics Market, by Localized Autoimmune Disease Diagnostics, by Region, 2020-2034 (USD million)
    • 6.4.2. Multiple Sclerosis
      • 6.4.2.1. Global Autoimmune Disease Diagnostics Market, by Multiple Sclerosis, by Region, 2020-2034 (USD million)
    • 6.4.3. Type 1 Diabetes
      • 6.4.3.1. Global Autoimmune Disease Diagnostics Market, by Type 1 Diabetes, by Region, 2020-2034 (USD million)
    • 6.4.4. Hashimoto's Thyroiditis
      • 6.4.4.1. Global Autoimmune Disease Diagnostics Market, by Hashimoto's Thyroiditis, by Region, 2020-2034 (USD million)
    • 6.4.5. Idiopathic Thrombocytopenic Purpura
      • 6.4.5.1. Global Autoimmune Disease Diagnostics Market, by Idiopathic Thrombocytopenic Purpura, by Region, 2020-2034 (USD million)
    • 6.4.6. Others
      • 6.4.6.1. Global Autoimmune Disease Diagnostics Market, by Others, by Region, 2020-2034 (USD million)

7. Global Autoimmune Disease Diagnostics Market, by Test Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • 7.3. Antinuclear Antibody (ANA) Tests
    • 7.3.1. Global Autoimmune Disease Diagnostics Market, by Antinuclear Antibody (ANA) Tests, by Region, 2020-2034 (USD million)
  • 7.4. Autoantibody Tests
    • 7.4.1. Global Autoimmune Disease Diagnostics Market, by Autoantibody Tests, by Region, 2020-2034 (USD million)
  • 7.5. Complete Blood Count (CBC)
    • 7.5.1. Global Autoimmune Disease Diagnostics Market, by Complete Blood Count (CBC) , by Region, 2020-2034 (USD million)
  • 7.6. Comprehensive Metabolic Panel
    • 7.6.1. Global Autoimmune Disease Diagnostics Market, by Comprehensive Metabolic Panel, by Region, 2020-2034 (USD million)
  • 7.7. C-Reactive Protein (CRP)
    • 7.7.1. Global Autoimmune Disease Diagnostics Market, by C-Reactive Protein (CRP), by Region, 2020-2034 (USD million)
  • 7.8. Others
    • 7.8.1. Global Autoimmune Disease Diagnostics Market, by Others, by Region, 2020-2034 (USD million)

8. Global Autoimmune Disease Diagnostics Market, by End User

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • 8.3. Hospitals
    • 8.3.1. Global Autoimmune Disease Diagnostics Market, by Hospitals, by Region, 2020-2034 (USD million)
  • 8.4. Diagnostics Centers
    • 8.4.1. Global Autoimmune Disease Diagnostics Market, by Diagnostics Centers, by Region, 2020-2034 (USD million)
  • 8.5. Research Laboratories
    • 8.5.1. Global Autoimmune Disease Diagnostics Market, by Research Laboratories, by Region, 2020-2034 (USD million)

9. Global Autoimmune Disease Diagnostics Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Autoimmune Disease Diagnostics Market Assessment, By Geography, 2020-2034 (USD million)
  • 9.3. Autoimmune Disease Diagnostics Market - North America
    • 9.3.1. North America: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
    • 9.3.2. North America: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
    • 9.3.3. North America: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
    • 9.3.4. North America: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.3.5. Autoimmune Disease Diagnostics Market - US
      • 9.3.5.1. US: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.3.5.2. US: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.3.5.3. US: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.3.5.4. US: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.3.6. Autoimmune Disease Diagnostics Market - Canada
      • 9.3.6.1. Canada: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.3.6.2. Canada: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.3.6.3. Canada: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.3.6.4. Canada: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • 9.4. Autoimmune Disease Diagnostics Market - Europe
    • 9.4.1. Europe: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
    • 9.4.2. Europe: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
    • 9.4.3. Europe: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
    • 9.4.4. Europe: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.4.5. Autoimmune Disease Diagnostics Market - UK
      • 9.4.5.1. UK: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.4.5.2. UK: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.4.5.3. UK: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.4.5.4. UK: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.4.6. Autoimmune Disease Diagnostics Market - France
      • 9.4.6.1. France: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.4.6.2. France: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.4.6.3. France: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.4.6.4. France: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.4.7. Autoimmune Disease Diagnostics Market - Germany
      • 9.4.7.1. Germany: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.4.7.2. Germany: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.4.7.3. Germany: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.4.7.4. Germany: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.4.8. Autoimmune Disease Diagnostics Market - Italy
      • 9.4.8.1. Italy: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.4.8.2. Italy: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.4.8.3. Italy: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.4.8.4. Italy: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.4.9. Autoimmune Disease Diagnostics Market - Spain
      • 9.4.9.1. Spain: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.4.9.2. Spain: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.4.9.3. Spain: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.4.9.4. Spain: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.4.10. Autoimmune Disease Diagnostics Market - Netherlands
      • 9.4.10.1. Netherlands: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.4.10.2. Netherlands: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.4.10.3. Netherlands: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.4.10.4. Netherlands: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.4.11. Autoimmune Disease Diagnostics Market - Russia
      • 9.4.11.1. Russia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.4.11.2. Russia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.4.11.3. Russia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.4.11.4. Russia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.4.12. Autoimmune Disease Diagnostics Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.4.12.2. Rest of Europe: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.4.12.3. Rest of Europe: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.4.12.4. Rest of Europe: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • 9.5. Autoimmune Disease Diagnostics Market - Asia Pacific
    • 9.5.1. Asia Pacific: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
    • 9.5.2. Asia Pacific: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
    • 9.5.3. Asia Pacific: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
    • 9.5.4. Asia Pacific: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.5.5. Autoimmune Disease Diagnostics Market - China
      • 9.5.5.1. China: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.5.5.2. China: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.5.5.3. China: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.5.5.4. China: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.5.6. Autoimmune Disease Diagnostics Market - India
      • 9.5.6.1. India: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.5.6.2. India: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.5.6.3. India: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.5.6.4. India: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.5.7. Autoimmune Disease Diagnostics Market - Malaysia
      • 9.5.7.1. Malaysia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.5.7.2. Malaysia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.5.7.3. Malaysia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.5.7.4. Malaysia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.5.8. Autoimmune Disease Diagnostics Market - Japan
      • 9.5.8.1. Japan: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.5.8.2. Japan: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.5.8.3. Japan: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.5.8.4. Japan: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.5.9. Autoimmune Disease Diagnostics Market - Indonesia
      • 9.5.9.1. Indonesia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.5.9.2. Indonesia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.5.9.3. Indonesia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.5.9.4. Indonesia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.5.10. Autoimmune Disease Diagnostics Market - South Korea
      • 9.5.10.1. South Korea: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.5.10.2. South Korea: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.5.10.3. South Korea: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.5.10.4. South Korea: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.5.11. Autoimmune Disease Diagnostics Market - Australia
      • 9.5.11.1. Australia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.5.11.2. Australia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.5.11.3. Australia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.5.11.4. Australia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.5.12. Autoimmune Disease Diagnostics Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.5.12.2. Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.5.12.3. Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.5.12.4. Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • 9.6. Autoimmune Disease Diagnostics Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
    • 9.6.2. Middle East & Africa: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
    • 9.6.3. Middle East & Africa: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
    • 9.6.4. Middle East & Africa: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.6.5. Autoimmune Disease Diagnostics Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.6.5.2. Saudi Arabia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.6.5.3. Saudi Arabia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.6.5.4. Saudi Arabia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.6.6. Autoimmune Disease Diagnostics Market - UAE
      • 9.6.6.1. UAE: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.6.6.2. UAE: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.6.6.3. UAE: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.6.6.4. UAE: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.6.7. Autoimmune Disease Diagnostics Market - Israel
      • 9.6.7.1. Israel: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.6.7.2. Israel: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.6.7.3. Israel: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.6.7.4. Israel: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.6.8. Autoimmune Disease Diagnostics Market - South Africa
      • 9.6.8.1. South Africa: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.6.8.2. South Africa: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.6.8.3. South Africa: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.6.8.4. South Africa: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.6.9. Autoimmune Disease Diagnostics Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.6.9.2. Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.6.9.3. Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.6.9.4. Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • 9.7. Autoimmune Disease Diagnostics Market - Latin America
    • 9.7.1. Latin America: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
    • 9.7.2. Latin America: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
    • 9.7.3. Latin America: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
    • 9.7.4. Latin America: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.7.5. Autoimmune Disease Diagnostics Market - Mexico
      • 9.7.5.1. Mexico: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.7.5.2. Mexico: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.7.5.3. Mexico: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.7.5.4. Mexico: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.7.6. Autoimmune Disease Diagnostics Market - Brazil
      • 9.7.6.1. Brazil: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.7.6.2. Brazil: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.7.6.3. Brazil: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.7.6.4. Brazil: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.7.7. Autoimmune Disease Diagnostics Market - Argentina
      • 9.7.7.1. Argentina: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.7.7.2. Argentina: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.7.7.3. Argentina: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.7.7.4. Argentina: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.7.8. Autoimmune Disease Diagnostics Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.7.8.2. Rest of Latin America: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.7.8.3. Rest of Latin America: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.7.8.4. Rest of Latin America: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Abbott
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. AESKU.DIAGNOSTICS
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Beckman Coulter, Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. BIOMERIEUX
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Bio-Rad Laboratories, Inc.
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. EUROIMMUN
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. F. Hoffmann-La Roche Ltd
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Inova Diagnostics (Werfen Group)
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Myriad Genetics, Inc.
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Quest Diagnostics
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Scipher Medicine
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Siemens Healthcare Private Limited
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Thermo Fisher Scientific Inc.
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development

List of Tables:

  • Table 1 Global Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 2 Global Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 3 Global Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 4 Global Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 5 North America: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 6 North America: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 7 North America: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 8 North America: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 9 US: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 10 US: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 11 US: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 12 US: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 13 Canada: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 14 Canada: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 15 Canada: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 16 Canada: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 17 Europe: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 18 Europe: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 19 Europe: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 20 Europe: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 21 UK: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 22 UK: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 23 UK: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 24 UK: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 25 France: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 26 France: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 27 France: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 28 France: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 29 Germany: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 30 Germany: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 31 Germany: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 32 Germany: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 33 Italy: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 34 Italy: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 35 Italy: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 36 Italy: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 37 Spain: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 38 Spain: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 39 Spain: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 40 Spain: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 41 Netherlands: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 42 Netherlands: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 43 Netherlands: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 44 Netherlands: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 45 Russia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 46 Russia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 47 Russia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 48 Russia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 49 Rest of Europe: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 50 Rest of Europe: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 51 Rest of Europe: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 52 Rest of Europe: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 53 Asia Pacific: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 54 Asia Pacific: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 55 Asia Pacific: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 56 Asia Pacific: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 57 China: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 58 China: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 59 China: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 60 China: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 61 India: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 62 India: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 63 India: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 64 India: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 65 Malaysia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 66 Malaysia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 67 Malaysia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 68 Malaysia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 69 Japan: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 70 Japan: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 71 Japan: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 72 Japan: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 73 Indonesia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 74 Indonesia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 75 Indonesia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 76 Indonesia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 77 South Korea: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 78 South Korea: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 79 South Korea: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 80 South Korea: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 81 Australia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 82 Australia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 83 Australia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 84 Australia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 85 Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 86 Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 87 Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 88 Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 89 Middle East & Africa: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 90 Middle East & Africa: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 91 Middle East & Africa: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 92 Middle East & Africa: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 93 Saudi Arabia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 94 Saudi Arabia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 95 Saudi Arabia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 96 Saudi Arabia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 97 UAE: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 98 UAE: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 99 UAE: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 100 UAE: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 101 Israel: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 102 Israel: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 103 Israel: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 104 Israel: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 105 South Africa: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 106 South Africa: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 107 South Africa: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 108 South Africa: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 109 Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 110 Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 111 Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 112 Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 113 Latin America: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 114 Latin America: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 115 Latin America: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 116 Latin America: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 117 Mexico: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 118 Mexico: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 119 Mexico: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 120 Mexico: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 121 Brazil: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 122 Brazil: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 123 Brazil: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 124 Brazil: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 125 Argentina: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 126 Argentina: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 127 Argentina: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 128 Argentina: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 129 Rest of Latin America: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 130 Rest of Latin America: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 131 Rest of Latin America: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 132 Rest of Latin America: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • List of Figures:
  • Figure 1. Global Autoimmune Disease Diagnostics Market, 2020-2034 (USD million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Autoimmune Disease Diagnostics Market, by Product, 2024 & 2034 (USD million)
  • Figure 8. Market by Type
  • Figure 9. Global Autoimmune Disease Diagnostics Market, by Type, 2024 & 2034 (USD million)
  • Figure 10. Market by Test Type
  • Figure 11. Global Autoimmune Disease Diagnostics Market, by Test Type, 2024 & 2034 (USD million)
  • Figure 12. Market by End User
  • Figure 13. Global Autoimmune Disease Diagnostics Market, by End User, 2024 & 2034 (USD million)